Aortic drug delivery of dexamethasone palmitate incorporated into lipid microspheres and its antiatherosclerotic effect in atherogenic mice

Journal of Drug Targeting

Volumn 13, Issue 7, 2005, Pages 407-414

  Chono, Sumio ^a   Tauchi, Yoshihiko ^a   Morimoto, Kazuhiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Atherogenic mice; Dexamethasone palmitate; Drug delivery system; Lipid microspheres; Macrophages and foam cells

Indexed keywords

CHOLESTEROL ESTER; DEXAMETHASONE; LIPID; MICROSPHERE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENCY; DRUG TISSUE LEVEL; FOAM CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LOW DRUG DOSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL ESTERS; DEXAMETHASONE; GLYCEROL; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; MICROSPHERES; PALMITATES; PHOSPHOLIPIDS; SOYBEAN OIL; TISSUE DISTRIBUTION;

EID: 30644466882     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860500383739     Document Type: Article

References (24)

1. Asai, K and Funai, C and Hayashi, T and Yamada, K and Naito, M and Kuzuya, M and Yamada, K and Yoshimine, N and Kuzuya, F. (1993) Dexamethasone-induces suppression of aortic atherosclerosis in cholesterol-fed rabbits Arterioscler Thromb, 13, pp. 892 - 899.
2. Branford, MM. (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem, 72, pp. 248 - 254.
3. Chono, S and Tauchi, Y and Deguchi, Y and Morimoto, K. (2005) Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice J Drug Target. in press
4. Hatch, F and Less, RS. (1968) Practical methods for plasma lipoprotein analysis Adv Lipid Res, 6, pp. 2 - 63.
5. Igarashi, R and Takenaga, M and Takeuchi, J and Kitagawa, A and Matsumoto, K and Mizushima, Y. (2001) Marked hypotensive and blood flow-increasing effects of a new lipo-PGE(1) (lipo-AS013) due to vascular wall targeting J Control Release, 71, pp. 157 - 164.
6. Makheja, AN and Bloom, S and Muesing, R and Simon, TM and Bailey, JM. (1989) Anti-inframmatory drugs in experimental atherosclerosis: 4. Inhibition of atherosclerosis in vivo and thromboxane synthesis and platelet aggregation in vivo Atherosclerosis, 76, pp. 155 - 161.
7. Mizushima, Y and Hamano, T and Yokoyama, K. (1982) Tissue distribution and anti-inframmatory activity of corticosteroids incorporated in lipid emulsion Ann Rheum Dis, 41, pp. 263 - 267.
8. Mizushima, Y and Hoshi, K. (1993) Review: Recent advances in lipid microsphere technology for targeting prostaglandin delivery J Drug Target, 1, pp. 93 - 100.
9. Naito, M and Yasue, M and Asai, K and Yamada, K and Hayashi, T and Kuzuya, M and Funai, C and Yoshimine, N and Kuzuya, F. (1992) Effect of dexamethasone on experimental atherosclerosis in cholesterol-fed rabbits J Nutr Sci Vitaminol, 38, pp. 255 - 264.
10. Ross, R. (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s Nature, 362, pp. 801 - 809.
11. Ross, R. (1999) Atherosclerosis-an inframmtory disease N Engl J Med, 340, pp. 115 - 126.
12. Ryu, BH and Mao, FW and Lou, P and Gutman, RL. (1995) Cholesterol ester accumulation in macrophages treated with oxidized low density lipoprotein Biosci Biotech Biochem, 59, pp. 1619 - 1622.
13. Takenaga, M and Igarashi, R and Tsuji, H and Mizushima, Y. (1993a) Enhanced antitumor activity and reduced toxicity of 1, 3-bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice Jpn J Cancer Res, 84, pp. 1078 - 1085.
14. Takenaga, M and Nakagawa, T and Igarashi, R and Mizushima, Y. (1993b) Application of lipid microspheres to prepare a thromboxane A2 receptor antagonist aerosol for inhalation J Drug Target, 1, pp. 293 - 301.
15. Tauchi, Y and Takase, M and Zushida, I and Chono, S and Sato, J and Ito, K and Morimoto, K. (1999) Preparation of a complex of dexamethasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages J Pharm Sci, 88, pp. 709 - 714.
16. Tauchi, Y and Takase, M and Zushida, I and Yokota, M and Chono, S and Sato, J and Ito, K and Morimoto, K. (2000) Inhibitory effect of dexamethasone palmitate-low density lipoprotein complex on low density lipoprotein-induced macrophage foam cell formation Biol Pharm Bull, 23, pp. 466 - 471.
17. Tauchi, Y and Zushida, I and Chono, S and Sato, J and Ito, K and Morimoto, K. (2001) Effect of dexamethasone palmitate-low density lipoprotein complex on cholesterol ester accumulation in aorta of atherogenic model mice Biol Pharm Bull, 24, pp. 925 - 929.
18. Tauchi, Y and Yoshimi, A and Shirahase, H and Sato, J and Ito, K and Morimoto, K. (2003) Inhibitory effect of acyl-CoA: Cholesterol acyltransferase inhibitor-low density lipoprotein complex on experimental atherosclerosis Biol Pharm Bull, 26, pp. 73 - 78.
19. Tedgui, A and Bernard, C. (1994) Cytokines, immuno-inframmatory response and atherosclerosis Eur Cytokine Network, 5, pp. 263 - 270.
20. Van Put, DJM and Van Hove, CE and De Meyer, GRY and Wuyts, F and Herman, AG and Bult, H. (1995) Dexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid artery Eur J Pharmacol, 294, pp. 753 - 761.
21. Witztum, JL and Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherosclerosis J Clin Investig, 88, pp. 1785 - 1792.
22. Yamaguchi, T and Mizushima, Y. (1994) Lipid microsphere for drug delivery from the pharmaceutical viewpoint Crit Rev Ther Drug Carrier Syst, 11, pp. 215 - 229.
23. Yamaguchi, Y and Kitagawa, S and Imaizumi, N and Kunitomo, M and Fujiwara, M. (1993) Enhancement of aortic cholesterol deposition by dietaary linoleic acid in cholesterol-fed mice: An animal model for primary screening of antiatherosclerotic agents J Pharmacol Toxicol Methods, 30, pp. 169 - 175.
24. Yla-Herttuala, S and Palinski, W and Rosenfeld, ME and Parthasarathy, S and Carew, TE and Butler, S and Witztum, JL and Steinberg, D. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabit and man J Clin Investig, 84, pp. 1086 - 1095.